Sonal Brahmbhatt
Vancouver, BC V6R1P2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Lessons from a National Liquid Biopsy Program to Provide Cancer Testing and Treatment for Patients with Advanced Solid Tumors.
Journal: Current oncology (Toronto, Ont.)
Published: November 01, 2025
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Journal: Cell reports
Published: April 05, 2025
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Journal: Cancer research
Published: July 09, 2020
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Journal: Genome medicine
Published: August 20, 2018
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
Journal: GigaScience
Published: April 28, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 20, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Journal: European urology
Published: December 14, 2016
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.
Journal: Oncotarget
Published: September 11, 2014
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.
Journal: Cell reports
Published: September 01, 2014
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.
Journal: Genome biology
Published: April 09, 2014
Last Updated: 09/26/2026